USP13 – A Master Regulator of Cellular Protein Homeostasis

Published by ANT BIO PTE. LTD.

1. Core Concepts

USP13 is a highly conserved ubiquitin‑specific protease that maintains protein homeostasis by cleaving K48‑ and K63‑linked ubiquitin chains. It contains a classic finger‑palm‑thumb catalytic fold with a Cys‑His‑Asp triad, plus unique terminal domains that mediate dynamic substrate interactions. USP13 governs proteostasis, autophagy, mitochondrial quality control, and stress responses, making it essential for cellular health and disease progression.

[Image Position: USP13 Protein Domain Structure and Catalytic Mechanism]

2. Research Frontiers

• Context‑dependent oncogenic and tumor‑suppressive roles of USP13
• Regulation of tau, α‑synuclein, and TDP‑43 in neurodegenerative diseases
• Control of autophagy, mitophagy, and ER stress pathways
• Metabolic reprogramming via glycolytic enzymes and the Warburg effect
• Development of selective USP13 inhibitors, PROTACs, and targeted therapies

3. Research Significance

USP13 dysfunction drives cancer, neurodegeneration, metabolic disorders, and liver disease. As a key regulator of proteostasis, it represents a high‑value therapeutic target. Reliable, isoform‑specific research tools are critical to dissect USP13 function, validate disease mechanisms, and accelerate drug discovery.

4. Key Mechanisms & Research Applications

4.1 Structure and Biochemical Regulation

USP13 is autoinhibited under basal conditions and activated by phosphorylation (Ser452, Thr675) and conformational changes. It localizes dynamically to the cytoplasm, mitochondria, ER, and nucleus in response to stress. It acts on >200 substrates, including p53, p62/SQSTM1, and RPN13, with biphasic concentration‑dependent effects.

4.2 Dual Role in Cancer

• Tumor‑suppressive: Stabilizes p53 in breast and ovarian cancers, improving survival.
• Oncogenic: Stabilizes c‑Myc, HIF‑1α, and PKM2 in prostate cancer and gliomas, driving metabolism, stemness, and immune evasion.
• Regulates PD‑L1 stability and immunotherapy resistance.

4.3 Roles in Neurodegenerative Diseases

• Alzheimer’s disease: Modulates tau ubiquitination and aggregation.
• Parkinson’s disease: Regulates α‑synuclein clearance and aggregate formation.
• ALS: Controls TDP‑43 phase separation, nuclear transport, and stress granules.

4.4 Autophagy and Mitochondrial Quality Control

• Stabilizes p62/SQSTM1 to promote autophagosome formation.
• Supports mitophagy via FUNDC1 and BNIP3.
• Maintains mitochondrial function and ATP production.
• Fine‑tunes ER stress and the unfolded protein response (UPR).

4.5 Therapeutic Targeting

• Selective small‑molecule inhibitors (e.g., DC‑U13‑022)
• CRISPR interference and base editing
• PROTACs, hypoxia‑activated prodrugs, and photomodulators

[Image Position: USP13 Signaling Network and Therapeutic Intervention Diagram]

5. Research Tools Empowered by ANT BIO PTE. LTD.

ANT BIO PTE. LTD. provides high‑performance reagents to accelerate USP13 research, including highly specific antibodies, activity kits, and recombinant proteins.

Core Product Advantages

Key Application Scenarios

6. Brand Mission

ANT BIO PTE. LTD. is a leading provider of professional life science reagents, offering high‑performance antibodies, recombinant proteins, detection kits, and general laboratory reagents. We operate three specialized sub‑brands: Absin (general reagents & kits), Starter (antibodies), and UA (recombinant proteins), delivering integrated solutions to advance global research in proteostasis, autophagy, cancer, and neurodegeneration.

7. Related Product List

9. Brand Promotion Copy

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.